| A comprehensive overview of exosomes as drug delivery vehicles—endogenous nanocarriers for targeted cancer therapy KB Johnsen, JM Gudbergsson, MN Skov, L Pilgaard, T Moos, M Duroux Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (1), 75-87, 2014 | 470 | 2014 |
| Proteasomal inhibition by α-synuclein filaments and oligomers E Lindersson, R Beedholm, P Højrup, T Moos, WP Gai, KB Hendil, ... Journal of Biological Chemistry 279 (13), 12924-12934, 2004 | 392 | 2004 |
| The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease B Mirza, H Hadberg, P Thomsen, T Moos Neuroscience 95 (2), 425-432, 1999 | 366 | 1999 |
| Iron trafficking inside the brain T Moos, TR Nielsen, T Skjørringe, EH Morgan Journal of neurochemistry 103 (5), 1730-1740, 2007 | 361 | 2007 |
| Transferrin and transferrin receptor function in brain barrier systems T Moos, EH Morgan Cellular and molecular neurobiology 20 (1), 77-95, 2000 | 349 | 2000 |
| The metabolism of neuronal iron and its pathogenic role in neurological disease T Moos, EH MORGAN Annals of the New York Academy of Sciences 1012 (1), 14-26, 2004 | 275 | 2004 |
| Strongly compromised inflammatory response to brain injury in interleukin‐6‐deficient mice M Penkowa, T Moos, J Carrasco, H Hadberg, A Molinero, H Bluethmann, ... Glia 25 (4), 343-357, 1999 | 212 | 1999 |
| Targeting Anti—Transferrin Receptor Antibody (OX26) and OX26-Conjugated Liposomes to Brain Capillary Endothelial Cells Using In Situ Perfusion S Gosk, C Vermehren, G Storm, T Moos Journal of Cerebral Blood Flow & Metabolism 24 (11), 1193-1204, 2004 | 169 | 2004 |
| CNS wound healing is severely depressed in metallothionein I-and II-deficient mice M Penkowa, J Carrasco, M Giralt, T Moos, J Hidalgo Journal of neuroscience 19 (7), 2535-2545, 1999 | 169 | 1999 |
| Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system T Moos Journal of Comparative Neurology 375 (4), 675-692, 1996 | 166 | 1996 |
| Restricted transport of anti‐transferrin receptor antibody (OX26) through the blood–brain barrier in the rat T Moos, EH Morgan Journal of neurochemistry 79 (1), 119-129, 2001 | 165 | 2001 |
| p25α stimulates α-synuclein aggregation and is co-localized with aggregated α-synuclein in α-synucleinopathies E Lindersson, D Lundvig, C Petersen, P Madsen, JR Nyengaard, ... Journal of Biological Chemistry 280 (7), 5703-5715, 2005 | 160 | 2005 |
| VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo S Gosk, T Moos, C Gottstein, G Bendas Biochimica et Biophysica Acta (BBA)-Biomembranes 1778 (4), 854-863, 2008 | 149 | 2008 |
| CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system JE Christensen, C de Lemos, T Moos, JP Christensen, AR Thomsen The Journal of Immunology 176 (7), 4235-4243, 2006 | 143 | 2006 |
| The vascular basement membrane in the healthy and pathological brain MS Thomsen, LJ Routhe, T Moos Journal of Cerebral Blood Flow & Metabolism 37 (10), 3300-3317, 2017 | 141 | 2017 |
| Brain iron homeostasis. T Moos Danish medical bulletin 49 (4), 279, 2002 | 130 | 2002 |
| Evidence for low molecular weight, non‐transferrin‐bound iron in rat brain and cerebrospinal fluid T Moos, EH Morgan Journal of neuroscience research 54 (4), 486-494, 1998 | 118 | 1998 |
| The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain T Moos, EH Morgan Journal of neurochemistry 88 (1), 233-245, 2004 | 108 | 2004 |
| Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration HH Andersen, KB Johnsen, T Moos Cellular and molecular life sciences 71 (9), 1607-1622, 2014 | 100 | 2014 |
| Efficient T-cell surveillance of the CNS requires expression of the CXC chemokine receptor 3 JE Christensen, A Nansen, T Moos, B Lu, C Gerard, JP Christensen, ... Journal of Neuroscience 24 (20), 4849-4858, 2004 | 93 | 2004 |
Kasper Bendix JohnsenColloids and Biological Interfaces Group, DTU Health Tech, DenmarkBekræftet mail på dtu.dk
